brand logo

Am Fam Physician. 1999;60(9):2508

to the editor: Walling's recent review of amyotrophic lateral sclerosis (ALS)1 was thorough and informative, but your readers might also like to know that the Muscular Dystrophy Association (MDA) is the nation's leading nonprofit, nongovernmental organization funding research and services for people with ALS.
For diagnosis and other medical services, physicians may wish to refer patients whom they suspect may have ALS to any of the 230 hospital-affiliated MDA clinics in our nationwide network or to one of the 19 MDA/ALS research/clinical facilities located at various major medical centers across the country. A directory of these facilities and information on ALS clinical trials, potential treatments and current research is available on the MDA Web site (http://www.mdausa.org).
MDA's services for patients with ALS and their families also include support groups and up-to-date information.
For copies of any MDA publications and videos about ALS, or referrals to the nearest MDA facility, physicians may check our Web site or call us at 800-572-1717.

Email letter submissions to afplet@aafp.org. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

Continue Reading


More in AFP

More in Pubmed

Copyright © 1999 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See https://www.aafp.org/about/this-site/permissions.html for copyright questions and/or permission requests.